News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Champions Oncology, Inc. (CSBR) and Teva Pharmaceutical Industries Limited (TEVA) Sign a Discovery and Drug Development Partnership



9/13/2013 9:02:00 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

HACKENSACK, N.J., Sept. 12, 2013 (GLOBE NEWSWIRE) -- Champions Oncology Inc. (OTC:CSBR) ("Champions"), a company engaged in the development of advanced technology solutions and services to personalize the development and use of oncology drugs, today announced the signing of a new discovery and drug development partnership with Teva Pharmaceutical Industries LTD (NYSE:TEVA) which will utilize Champions TumorGraft™ technology platform to enhance and accelerate the clinical development of several of Teva's oncology compounds.

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES